Abstract: An implantable article for cartilage repair by implantation in an animal. The implantable article includes a support matrix, and chondrocyte cells and a bio-compatible adhesive adhered to an edge of the support matrix, wherein the support matrix is absorbable by the animal. The support matrix is a biocompatible material such as collagen, and the adhesive is autologous fibrin.
Type:
Grant
Filed:
March 26, 2003
Date of Patent:
November 21, 2006
Assignee:
Verigen AG
Inventors:
Samuel S. Asculai, Ahmed Idouraine, Bruno Giannetti
Abstract: Method for the effective transplantation of chondrocytes/cartilage to an articular joint surface defect is taught, as well as a description of certain instruments and kit for practicing the invention.
Type:
Grant
Filed:
May 23, 2003
Date of Patent:
May 23, 2006
Assignee:
Verigen AG
Inventors:
Henrik Vibe-Hansen, Charlotte Lundsgaard, Kurt B. Osther, Ahmed Idouraine
Abstract: The present invention relates to a method for the effective treatment of tissue defects and for tissue regeneration. The method includes seeding autologous cells on a support matrix and implanting the cell-seeded support matrix into a site of transplantation. The present invention also relates to various tissue repair structures that include cells seeded onto a cell-free membrane. The present invention also provides methods for cultivation, seeding, and implantation of autologous cells.
Abstract: The present invention relates to a flowable implantable composition comprising a support material, such as various forms of collagen or alginate beads or threads, which can support the attachment and growth of chondrocyte cells thereto, ad a method of making a flowable implantable composition comprising a support material and chondrocytes retained thereon. Further, the present invention relates to a method for the effective treatment of articulating joint surface cartilage by the transplantation of a flowable composition including a support material and chondrocyte cells retained thereon.
Abstract: A biocompatible, resorbable Type II collagen-based matrix is reconstituted from solubilized animal cartilage tissue and used in the culture and growth of cells, such as chondrocyte cells. The matrix is produced by isolating cartilage tissue, solubilizing and reconstituting the cartilage to form a fleece-like material, pressing the fleece-like material to form a sheet-like article, and sterilizing the article. An implantable article for cartilage repair includes chondrocyte cells retained on the matrix.
Type:
Grant
Filed:
December 20, 1999
Date of Patent:
September 23, 2003
Assignees:
Verigen AG
Inventors:
Peter Karl Müller, Peter Behrens, Bruno Giannetti, Jürgen Rohwedel, Martin Russlies